The Role of Peripheral Afferents in Modulating Post-stroke Central Pain

NCT06446960 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

36

Enrollment

OTHER_GOV

Sponsor class

Conditions

Stroke

Interventions

DRUG: Lidocaine 20mg/ml
DRUG: Levobupivacaine Hydrochloride 1.25 MG/ML
DRUG: Sodium Chloride 0.9% Inj

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France